Brawn Biotech Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 33.7 million compared to INR 67.752 million a year ago. Net loss was INR 6.023 million compared to INR 3.227 million a year ago. Basic loss per share from continuing operations was INR 1.5 compared to INR 0.8 a year ago. For the full year, total revenue was INR 352.848 million compared to INR 497.871 million a year ago. Net loss was INR 5.506 million compared to net income of INR 5.913 million a year ago. Basic loss per share from continuing operations was INR 1.55 compared to basic earnings per share from continuing operations of INR 2.01 a year ago.